| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
911 |
475 |
$27K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
642 |
347 |
$10K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
208 |
105 |
$9K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
232 |
132 |
$9K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
358 |
208 |
$5K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
789 |
237 |
$5K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
115 |
36 |
$537.07 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
78 |
56 |
$506.31 |
| 86710 |
|
42 |
26 |
$476.38 |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
18 |
12 |
$395.00 |
| 99401 |
|
25 |
15 |
$216.96 |
| 87400 |
|
26 |
12 |
$198.07 |
| 36415 |
Collection of venous blood by venipuncture |
50 |
32 |
$48.54 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
47 |
15 |
$23.92 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
59 |
19 |
$8.86 |
| A4208 |
Syringe with needle, sterile 3 cc, each |
20 |
13 |
$0.00 |
| 99000 |
|
67 |
32 |
$0.00 |